Scynexis (SCYX) Times Interest Earned (2013 - 2026)
Scynexis (SCYX) posted Times Interest Earned of -$677.56 for Q1 2026, down 1490.7% on a QoQ basis from -$42.6 in Q4 2025, and down 3205.17% year-over-year from $21.82 in Q1 2025.
Scynexis (SCYX) Times Interest Earned (2013 - 2026) Analysis & Trends
Scynexis' Times Interest Earned history runs 14 years deep, the most recent figure standing at -$677.56 for Q1 2026.
- Quarterly Times Interest Earned fell 3205.17% year-over-year to -$677.56 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$975.36 (down 3336.11% YoY) and the FY2025 annual result came in at -$21.6, down 3891.57% from the prior year.
- Times Interest Earned was -$677.56 for Q1 2026 at Scynexis, down from -$42.6 in the prior quarter.
- Across five years, Times Interest Earned topped out at $93.29 in Q2 2023 and bottomed at -$1681.0 in Q3 2025.
- A 5-year average of -$161.14 and a median of -$21.57 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned jumped 628.27% — and 2025, when it sank 3369.51%.
- Scynexis' Times Interest Earned stood at $8.08 in 2022, then plunged by 209.91% to -$8.88 in 2023, then plunged by 306.45% to -$36.11 in 2024, then dropped by 17.95% to -$42.6 in 2025, then plunged by 1490.7% to -$677.56 in 2026.
- Business Quant data shows SCYX's Times Interest Earned at -$677.56 in Q1 2026, -$42.6 in Q4 2025, and -$1681.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | -677.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -677.56 |
| Dec 31, 2025 | -42.60 |
| Sep 30, 2025 | -1,681.00 |
| Mar 31, 2025 | -20.50 |
| Dec 31, 2024 | -36.11 |
| Sep 30, 2024 | -48.45 |
| Jun 30, 2024 | -36.37 |
| Mar 31, 2024 | -22.64 |
| Dec 31, 2023 | -8.88 |
| Sep 30, 2023 | -47.63 |
| Jun 30, 2023 | 93.29 |
| Mar 31, 2023 | -6.44 |
| Dec 31, 2022 | 8.08 |
| Sep 30, 2022 | -15.81 |
| Jun 30, 2022 | -17.66 |
| Mar 31, 2022 | -17.96 |
| Dec 31, 2021 | -20.44 |
| Sep 30, 2021 | -19.08 |
| Jun 30, 2021 | -39.34 |
| Mar 31, 2021 | -3.80 |